NEWS

We are excited to share the news that NovoPedics' total meniscus replacement device currently in development recently received  Breakthrough Device Designation from the U.S. Food and Drug Administration.

​

Click to view:

Novopedics press release

Novopedics website 

​

FVCG invested in NovoPedics in 2013.

FVCG Sells Interest in Durin​

We have sold our equity interest in Durin Technologies, Inc. (Durin) to Breakthrough Diagnostics, Inc. 

Durin was founded by Robert G. Nagele, PhD (pictured above), a professor and researcher at Rowan University School of Osteopathic Medicine, pursuing the development of blood tests to detect neurodegenerative diseases at very early stages. 

​